Found 5 resultsAuthor [ Title] Type Year
Filters: Author is Walter, EB [Clear All Filters]
Clinical and Immune Responses to Inactivated Influenza A(H1N1)pdm09 Vaccine in Children. Pediatr Infect Dis J, 33, 865-871. presented at the 08/2014. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25222307. (2014).
Immunogenicity of Avian Influenza A/Anhui/01/2005(H5N1) Vaccine with MF59 Adjuvant: A Randomized Clinical Trial. JAMA, 312, 1420-1428. presented at the 10/2014. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25291578. (2014).
Phase 2 Assessment of the Safety and Immunogenicity of Two Inactivated Pandemic Monovalent H1N1 Vaccines in Adults as a Component of the U.S. Pandemic Preparedness Plan in 2009. Vaccine, 13, 4240-4248. presented at the 06/2012. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed?term=22537984. (2012).
Safety and Immunogenicity of an Inactivated Influenza A/H5N1 Vaccine Given Without or With Aluminum Hydroxide to Healthy Adults: Results of a Phase I-II Randomized Clinical Trial. J Infec Dis, 198, 1309-1316. presented at the 11/2009. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/18808338. (2009).
Safety and Immunogenicity of Tetanus Diphtheria and Acellular Pertussis (Tdap) Immunization During Pregnancy in Mothers and Infants: A Randomized Clinical Trial. JAMA, 311, 1760-1769. presented at the 05/2014. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24794369. (2014).